Health Condition 1: K049- Other and unspecified diseases ofpulp and periapical tissues
Conditions
Interventions
Intervention1: Ibugesic (Ibuprofen + Paracetamol)(tablet)
1.Ibugesic 200mg
2.Ibugesic 400mg: Administered orally as a single dose 30 minutes prior to the dental procedure. Dosage calculated based on b
Sponsors
Somya Seth
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children aged 4 to 9 years. 2.Children who need pulpectomy in mandibular primary molar 3.Children who are healthy (ASA I or II). 4.Children who can understand and follow simple instructions. 5.Children having Frankl Behaviour rating scale of 3 or 4. 6.Children whose parents or guardians give written consent to take part in the study.
Exclusion criteria
Exclusion criteria: 1.Children who have allergies to any pain medication (like ibuprofen or paracetamol). 2.Children who are already taking painkillers or antibiotics before the treatment. 3.Children with acute infections, facial swelling, or abscess near the tooth. 4.Children with serious medical problems (e.g., heart conditions, kidney or liver disease). 5.Children with special healthcare needs or behavioral issues that may affect treatment. 6.Children who have received pulpectomy treatment in the same tooth earlier. 7.Children whose tooth is indicated for extraction (e.g., due to severe decay, mobility).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in postoperative pain following primary molar pulpectomy in children.Timepoint: 1.During local anaesthesia injection. 2.During the procedure 3.1 hour post procedure 4.4 hours post procedure 5.6 hours post procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDinesh Kumar B
Saveetha Dental College and Hospitals
Outcome results
None listed